Efficacy of ETV-CPC in Infants

Status: draft · Last updated 2026-10-23 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • CPC adds benefit under 1 year: Warf found 66% success with ETV-CPC vs 47% with ETV alone. There was no difference at ≥1 year (80% for each) .
  • Biggest gains by etiology: myelomeningocele (76% vs 35%) and non-postinfectious hydrocephalus (70% vs 38%). The difference in postinfectious hydrocephalus was not significant .
  • Myelomeningocele: 76% success. 86% of failures happened before 6 months and none after 10 months. Cistern or choroid plexus scarring predicted failure; age did not . Pooled MMC data show 75% for ETV-CPC vs 48% for ETV alone .
  • Uganda RCT, postinfectious hydrocephalus: ETV-CPC and shunting were equivalent at 1, 2 and 5 years for development, treatment failure and brain volume . Brain growth stalled in the 2nd year in both arms .
  • Pooled success: 59% overall in 1,918 infants . By etiology: aqueductal stenosis 71%, myelomeningocele 70%, postinfectious 64%, posthemorrhagic 52% .
  • Setting matters: pooled success was 71% in sub-Saharan Africa vs 49% in North America .
  • HCRN prospective study: 36% success at 6 months. ETV-CPC failed more often than shunting in matched infants. Complications included seizures (5.1%) and CSF leak (3.4%) .
  • HCRN predictors of failure: age <1 month (aHR 1.9) and post-IVH of prematurity (aHR 2.0) .
  • Predictors of success: older age, smaller ventricles and greater extent of CPC . Failure HR was 4.4 with <90% CPC, a borderline result (95% CI 1.0–19.2, p = 0.05) .
  • ETVSS: validated for ETV alone, not ETV-CPC .

Landmark papers

  • Warf (Warf, J Neurosurg 2005): a prospective study of 550 African children. In infants under one year, ETV-CPC succeeded in 66% vs 47% with ETV alone, with no difference at 1 year or older .
  • Uganda randomized trial (Kulkarni et al., N Engl J Med 2017): 100 Ugandan infants with postinfectious hydrocephalus were assigned to ETV-CPC or a ventriculoperitoneal shunt. There was no significant difference in cognitive scores, treatment failure or brain volume at 12 months .
  • HCRN prospective study (Kulkarni et al., J Neurosurg Pediatr 2018): in North American infants, 6-month success was 36%, and failure was higher than with shunting in matched infants .

Bottom line

Endoscopic third ventriculostomy combined with choroid plexus cauterization (ETV-CPC) is an established way to treat some infants with hydrocephalus without a shunt, but how well it works depends heavily on etiology, age and setting. In Warf's prospective Ugandan series, adding CPC to ETV improved success in infants under one year (66% vs 47%), with the largest benefit in myelomeningocele (76% vs 35%) and non-postinfectious hydrocephalus (70% vs 38%); there was no difference in children one year or older . In a prospective cohort of 115 East African infants with myelomeningocele, ETV-CPC succeeded in 76%, nearly all failures occurred before six months, and scarring of the prepontine cistern or of the choroid plexus predicted failure . In the only randomized trial, 100 Ugandan infants with postinfectious hydrocephalus were assigned to ETV-CPC or a ventriculoperitoneal shunt. The trial found no significant difference in cognitive scores, treatment failure or brain volume at 12 months , at 2 years or at 5 years . Pooled analyses put overall success at about 59–63%, but they rest largely on retrospective series with publication bias. By etiology, success is highest in aqueductal stenosis (71%) and myelomeningocele (70%) and lowest in posthemorrhagic hydrocephalus (52%) . North American results are lower. Pooled North American series reached 49%, compared with 71% in sub-Saharan Africa . In the Hydrocephalus Clinical Research Network's prospective study (HCRN, a multicenter North American research group), 6-month success was 36%, and failure was higher than with shunting in matched infants . A larger HCRN cohort reported 48% success at 6 months and 45% at 18 months. In that cohort, age under one month and hemorrhage-related hydrocephalus of prematurity (post-IVH) independently predicted failure . Success rose with older age, smaller ventricles and a more extensive cauterization , and an earlier HCRN series found a borderline-significant rise in failure with <90% CPC (HR 4.4, p = 0.05) . Formal ETV-CPC training increased complete cauterization but did not independently improve outcomes . The standard ETV Success Score (ETVSS) was developed and recently re-validated in children treated with ETV alone, excluding CPC cases. It has not been validated for ETV-CPC . Overall, ETV-CPC is a reasonable first-line option for selected infants, especially where reliable long-term shunt care isn't available. In North American practice, success depends on careful patient selection and a near-complete cauterization, and it remains well below that of shunting.

Related topics

References

  1. Warf BC. Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infants younger than 1 year of age: a prospective study in 550 African children. J Neurosurg 2005;103(6 Suppl):475–481. doi:10.3171/ped.2005.103.6.0475. PMID 16383244. verified
  2. Warf BC, Campbell JW. Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants. J Neurosurg Pediatr 2008;2(5):310–316. doi:10.3171/PED.2008.2.11.310. PMID 18976099. verified
  3. Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, et al. Endoscopic treatment versus shunting for infant hydrocephalus in Uganda. N Engl J Med 2017;377(25):2456–2464. doi:10.1056/NEJMoa1707568. PMID 29262276. verified
  4. Schiff SJ, Kulkarni AV, Mbabazi-Kabachelor E, et al. Brain growth after surgical treatment for infant postinfectious hydrocephalus in Sub-Saharan Africa: 2-year results of a randomized trial. J Neurosurg Pediatr 2021;28(3):326–334. doi:10.3171/2021.2.PEDS20949. PMID 34243157. verified
  5. Mbabazi-Kabachelor E, Peterson MR, Mugamba J, et al. Five-year outcomes after surgical treatment of infant postinfectious hydrocephalus in sub-Saharan Africa: results of a randomized trial. J Neurosurg Pediatr 2025;36(2):135–144. doi:10.3171/2025.1.PEDS24417. PMID 40315611. verified
  6. Weil AG, Westwick H, Wang S, et al. Efficacy and safety of endoscopic third ventriculostomy and choroid plexus cauterization for infantile hydrocephalus: a systematic review and meta-analysis. Childs Nerv Syst 2016;32(11):2119–2131. doi:10.1007/s00381-016-3236-6. PMID 27613635. verified
  7. Albalkhi I, et al. Morbidity and etiology-based success rate of combined endoscopic ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis of 1918 infants. Neurosurg Rev 2023;46(1):180. doi:10.1007/s10143-023-02091-4. PMID 37468790. verified
  8. Kulkarni AV, Riva-Cambrin J, Rozzelle CJ, et al. Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus: a prospective study by the Hydrocephalus Clinical Research Network. J Neurosurg Pediatr 2018;21(3):214–223. doi:10.3171/2017.8.PEDS17217. PMID 29243972. verified
  9. Riva-Cambrin J, Kestle JRW, Rozzelle CJ, et al. Predictors of success for combined endoscopic third ventriculostomy and choroid plexus cauterization in a North American setting: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2019;24(2):128–138. doi:10.3171/2019.3.PEDS18532. PMID 31151098. verified
  10. Kulkarni AV, Riva-Cambrin J, Browd SR, et al. Endoscopic third ventriculostomy and choroid plexus cauterization in infants with hydrocephalus: a retrospective Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2014;14(3):224–229. doi:10.3171/2014.6.PEDS13492. PMID 24995823. verified
  11. Verhey LH, et al. A re-evaluation of the Endoscopic Third Ventriculostomy Success Score: a Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr 2024;33(5):417–427. doi:10.3171/2023.12.PEDS23401. PMID 38335514. verified
  12. Omar AT 2nd, Espiritu AI, Spears J. Endoscopic third ventriculostomy with or without choroid plexus coagulation for myelomeningocele-associated hydrocephalus: systematic review and meta-analysis. J Neurosurg Pediatr 2022;29(4):435–443. doi:10.3171/2021.11.PEDS21505. PMID 35061994. verified

Verification (2026-10-23): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited here was checked against the PubMed abstract. Full texts were not reviewed.